Cargando…

The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain

Salvinorin A (SA) is a κ-opioid receptor agonist and atypical dissociative hallucinogen found in Salvia divinorum. Despite the resurgence of hallucinogen studies, the effects of κ-opioid agonists on human brain function are not well-understood. This placebo-controlled, within-subject study used func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doss, Manoj K., May, Darrick G., Johnson, Matthew W., Clifton, John M., Hedrick, Sidnee L., Prisinzano, Thomas E., Griffiths, Roland R., Barrett, Frederick S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532139/ https://www.ncbi.nlm.nih.gov/pubmed/33009457 http://dx.doi.org/10.1038/s41598-020-73216-8

Ejemplares similares

Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis
por: Duvvuru, Bhawyanth, et al.
Publicado: (2023)

Rapid Detection and Quantification of Hallucinogenic Salvinorin A in Commercial Salvia divinorum Products by DART-HRMS
por: Chambers, Megan I., et al.
Publicado: (2022)

The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis
por: Paton, Kelly F., et al.
Publicado: (2021)

Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A
por: Vasiljevik, Tamara, et al.
Publicado: (2014)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan
por: Lin, Po-Xiang, et al.
Publicado: (2014)

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain
por: Paton, Kelly F., et al.
Publicado: (2020)

Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues
por: Riley, Andrew P., et al.
Publicado: (2014)

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2015)

Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs
por: Oster, Ena, et al.
Publicado: (2023)

Brain mechanisms of hallucinogens and entactogens
por: Vollenweider, Franz X.
Publicado: (2001)

Is Shame Hallucinogenic?
por: McCarthy-Jones, Simon
Publicado: (2017)

Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002–2019
por: Walsh, Claire A., et al.
Publicado: (2022)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
por: Jones, Grant, et al.
Publicado: (2023)

Formal Total Synthesis of Salvinorin A
por: Halang, Marc, et al.
Publicado: (2022)

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2016)

Poisonous & hallucinogenic mushrooms
por: Haard, Richard
Publicado: (1980)

Salvinorin B methoxymethyl ether
por: Munro, Thomas A., et al.
Publicado: (2012)

Emotions and brain function are altered up to one month after a single high dose of psilocybin
por: Barrett, Frederick S., et al.
Publicado: (2020)

“Hallucinations” Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs
por: Barrett, Frederick S., et al.
Publicado: (2018)

Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023)

Unusual hemiacetal structure derived from Salvinorin A
por: Carvalho, Paulo, et al.
Publicado: (2008)

Kappa Opioids, Salvinorin A and Major Depressive Disorder
por: Taylor, George T., et al.
Publicado: (2016)

Salvinorin A Does Not Affect Seizure Threshold in Mice
por: Socała, Katarzyna, et al.
Publicado: (2020)

A Protecting‐Group‐Free Synthesis of (−)‐Salvinorin A
por: Zimdars, Patrick, et al.
Publicado: (2021)

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents
por: Kivell, Bronwyn M., et al.
Publicado: (2018)

Hallucinogenic and poisonous mushroom field guide /
por: Menser, Gary P.
Publicado: (1977)

Psychedelic medicine and the clinical application of hallucinogens
por: eClinicalMedicine
Publicado: (2023)

Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization
por: Rossi, Antonietta, et al.
Publicado: (2017)

A Route to Potent, Selective, and Biased Salvinorin Chemical Space
por: Hill, Sarah J., et al.
Publicado: (2023)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens
por: Müller, Felix, et al.
Publicado: (2020)

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain
por: Spain, Aisling, et al.
Publicado: (2015)

Modulation of Social Cognition via Hallucinogens and “Entactogens”
por: Preller, Katrin H., et al.
Publicado: (2019)

The Potential Role of Serotonergic Hallucinogens in Depression Treatment
por: Psiuk, Dominika, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects
por: Brito-da-Costa, Andreia Machado, et al.
Publicado: (2021)

Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
por: Cichon, Joseph, et al.
Publicado: (2022)

Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?
por: Müller, Felix, et al.
Publicado: (2020)

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
por: van de Wetering, Ross, et al.
Publicado: (2023)

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor
por: Munro, Thomas A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_lcodmh0jv65jcuttj97fl8fral